S1PR2 and cancer: KRasV12 is an important driver for the same cancers that lack S1P2—pancreatic, lung, and colon carcinomas—and its expression alone reduces S1P2 (Slattum et al., 2014), which may explain why PanIN precursors have reduced S1P2 expression.